Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0000950170-24-013569
Filing Date
2024-02-12
Accepted
2024-02-12 08:00:24
Documents
17
Period of Report
2024-02-12

Document Format Files

Seq Description Document Type Size
1 PRE 14A amrn-20240212.htm   iXBRL PRE 14A 1914615
2 GRAPHIC img153231720_0.jpg GRAPHIC 7999
3 GRAPHIC img153231720_1.jpg GRAPHIC 393605
4 GRAPHIC img153231720_2.jpg GRAPHIC 337220
5 GRAPHIC img153231720_3.jpg GRAPHIC 248237
  Complete submission text file 0000950170-24-013569.txt   5755419

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT amrn-20240212.xsd EX-101.SCH 39864
18 EXTRACTED XBRL INSTANCE DOCUMENT amrn-20240212_htm.xml XML 577453
Mailing Address SPACES SOUTH DOCKLANDS, BLOCK C 77 SIR JOHN ROGERSON'S QUAY DUBLIN 2 L2 D02 VK60
Business Address SPACES SOUTH DOCKLANDS, BLOCK C 77 SIR JOHN ROGERSON'S QUAY DUBLIN 2 L2 D02 VK60 353 1 6699 020
AMARIN CORP PLC\UK (Filer) CIK: 0000897448 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 000-21392 | Film No.: 24617421
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)